ESLA fundamentals
An in-depth look to Estrella Immunopharma, Inc. operating, investing, and financing activities
ESLA free cash flow for Q1 25 is -2.22 M USD. For 2024, ESLA free cash flow was -16.07 M USD and operating cash flow was -16.07 M USD.
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
TTM